John M. Kane, MD | Psychiatrist.com

Consensus Statement

Revisiting the Use of the AIMS in Tardive Dyskinesia Trials

May 8, 2018

The authors of this consensus statement look at the history of the use of the Abnormal Involuntary Movement Scale in tardive dyskinesia studies and outline the challenges of using...

John M. Kane, Christoph U. Correll, Andrew A. Nierenberg, et al

Educational Activity

Assessing Patients for Tardive Dyskinesia

December 27, 2017

John M. Kane

Letter to the Editor

Dr Correll and Colleagues Reply

October 25, 2017

Christoph U. Correll, Leslie Citrome, Peter M. Haddad, et al

Academic Highlights

Epidemiology, Prevention, and Assessment of TD

October 10, 2017

Is your patient experiencing involuntary movements of the face, torso, or extremities? It could be tardive dyskinesia, a side effect of antipsychotic medications. Explore this CME Academic Highlights activity...

Christoph U. Correll, John M. Kane, Leslie L. Citrome

Article

Early Response in Adolescents With Bipolar Disorder

September 5, 2017

Early treatment response in adults with acute mania is a good predictor of ultimate response and remission. Read this article by Xiao and colleagues to see if response to...

Le Xiao, Stephen J. Ganocy, Robert L. Findling, et al

Review Article

Technology-Assisted Parent Training

May 9, 2017

Want to do more than prescribe psychotropic medications for youth with disruptive behaviors? Read this systematic review for the latest research on how digitally-assisted parent training programs are being...

Amit Baumel, Aditya Pawar, Nandita Mathur, et al

Meta-Analysis

Tardive Dyskinesia Prevalence

March 29, 2017

With the advent of second-generation antipsychotics, hopes were high that tardive dyskinesia would all but disappear as a side effect. However, it persists. In this meta-analysis, Carbon et al...

Maren Carbon, Cheng-Hsi Hsieh, John M. Kane, et al

Meta-Analysis

Neurocognition in Clinical High Risk for Psychosis

January 25, 2017

Is your patient showing signs of what might be an early phase of prepsychotic illness? Read this meta-analysis for information on how specific cognitive impairments hold promise for predicting...

Marta Hauser, Jian-Ping Zhang, Eva M. Sheridan, et al

Original Research

Lurasidone in Early Nonresponding Schizophrenia

December 28, 2016

What's the next step when a patient doesn' t respond to an antipsychotic? Should you augment, switch medications, wait and see, or raise the dose? Read this study in...

Antony Loebel, Robert Silva, Robert Goldman, et al

Supplement Article

Injectable Antipsychotics in Schizophrenia

September 30, 2016

Read the recommendations of experts on the use of long-acting injectable antipsychotic medications in patients with schizophrenia.

Christoph U. Correll, Leslie Citrome, Peter M. Haddad, et al

Review Article

Benign Ethnic Neutropenia & Clozapine Use

July 27, 2016

Read a full review examining whether Benign Ethnic Neutropenia (BEN) should prevent treatment with clozapine.

Peter Manu, Nilofar Sarvaiya, Liliana M. Rogozea, et al

Original Research

Clozapine and Risperidone in Moderately Refractory Schizophrenia: A 6-Month Randomized Double-Blind Comparison

May 25, 2016

Nina R. Schooler, Stephen R. Marder, K. N. R. Chengappa, et al

« 1 2 3 4 … 10 »